Hebert et al. (2008) reported high BACE 1 expression in postmortem brains of AD patients as well as a decreased expression of several miRNAs with candidate binding sites within 3′ UTRs of BACE1 [51]. This evidence concerns the gene BACE1 and Alzheimer disease.